Varex Imaging Corp Stock News

Boston Scientific's (BSX) new acquisitions like Preventice, Farapulse and Lumenis Surgical, which closed in March, August and September of 2021, respectively, are contributing to its inorganic growth.

Alcon (ALC) enhances contact lens experience, especially for new wearers, with the continued successful rollout of PRECISION1.

Robust performance of the base business and COVID-19 testing volume gains are driving the top line for Quest Diagnostics (DGX).

Featured Top IdeaVREX Varex Imaging CorporationAction: Trade: Buy 2027 7.875% Bonds, CUSIP: 92214XAC0 (5.236% YTW, 3.986% iYTW) Aggregate Credit Market and Credit Fundamental ReviewRecently, the Aggregate cost to borrow for all credits (High Yield HY, Cross-Over XO, and Investment Grade IG) has broken from the exceptionally low levels it has been in for Read More The post Valens Credit Weekly Insights for December 15, 2021 appeared first on Valens Research .

Robust performance by the Pharmacy Services and Health Care Benefits arms is driving the top line for CVS Health (CVS).

Hologic's (HOLX) latest data on Breast Cancer Index demonstrates its effectiveness in predicting net benefit from extended endocrine therapy.

Investors are optimistic about Insulet's (PODD) better-than-expected revenues and solid revenue growth across the Omnipod product line.

Thermo Fisher's (TMO) acquisition of PPD is likely to bolster its Laboratory Products and Services arm.

NextGen's (NXGN) comprehensive solution suite was adopted by Monmouth to better cater to patients' medical and dental needs.

QIAGEN's (QGEN) QuantiFERON SARS-CoV-2 assay enables a comprehensive assessment of immunity developed by COVID-19 vaccines.

The clinical use of Change Healthcare's (CHNG) cloud-native Stratus Imaging PACS is likely to enhance radiologists' productivity.

Investors are optimistic about IDEXX's (IDXX) better-than-expected results and continued international growth in the third quarter.

According to the new market research report "X-Ray Detectors Market by Technology (Flat Panel, CCD, CR Detector), Application (Medical, Orthopedic, Industrial, Veterinary, Security), FPD (Type (Gadox, CSL, Direct), Portability (Fix, Portable), Platform (Digital, Retrofit)) - Global Forecast to 2026", published

Equities research analysts expect that Varex Imaging Co. (NASDAQ:VREX) will report sales of $210.05 million for the current quarter, Zacks reports. Two analysts have made estimates for Varex Imagings earnings. The highest sales estimate is $210.10 million and the lowest is $210.00 million. Varex Imaging posted sales of $177.10 million in the same quarter last []

Bruker's (BRKR) FluoroType SARS-CoV-2 varID Q assay is anticipated to provide reliable detection of the novel Omicron (B.1.1.529) variant of SARS-CoV-2.